Galectin Therapeutics (GALT) Enterprise Value (2010 - 2026)
Galectin Therapeutics (GALT) recorded Enterprise Value of $294.39 million in Q2 2026, up 142.5% from $121.4 million a year earlier and up 73.5% from the prior quarter.
Galectin Therapeutics (GALT) Enterprise Value (2010 - 2026) Analysis & Trends
On a TTM basis, Galectin Therapeutics' Enterprise Value came in at $251.03 million as of Jun 30, 2026, up 249.7% year-over-year; for FY2025, it was $253.52 million, up 282.1% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of 20.3% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $66.35 million in FY2024 (-13.8%), $77.02 million in FY2023 (+58.6%), $48.56 million in FY2022 (-41.6%) and $83.19 million in FY2021 (-17.4%).
- The Q2 2026 figure is the highest quarterly Enterprise Value since Q1 2014.
- On a year-over-year basis, Enterprise Value has increased for five consecutive quarters, with growth averaging 80.4% over the last eight quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 282.1% in Q4 2025, against a decline of 66.1% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $169.63 million (Q1 2026), $253.52 million (Q4 2025) and $261.84 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Galectin Therapeutics | 260.61 Mn | 260.61 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 294.39 Mn |
| Mar 31, 2026 | 169.63 Mn |
| Dec 31, 2025 | 253.52 Mn |
| Sep 30, 2025 | 261.84 Mn |
| Jun 30, 2025 | 121.40 Mn |
| Mar 31, 2025 | 69.78 Mn |
| Dec 31, 2024 | 66.35 Mn |
| Sep 30, 2024 | 144.29 Mn |
| Jun 30, 2024 | 115.15 Mn |
| Mar 31, 2024 | 124.98 Mn |
| Dec 31, 2023 | 77.02 Mn |
| Sep 30, 2023 | 98.39 Mn |
| Jun 30, 2023 | 67.83 Mn |
| Mar 31, 2023 | 107.32 Mn |
| Dec 31, 2022 | 48.56 Mn |
| Sep 30, 2022 | 81.03 Mn |
| Jun 30, 2022 | 53.63 Mn |
| Mar 31, 2022 | 64.01 Mn |
| Dec 31, 2021 | 83.19 Mn |
| Sep 30, 2021 | 193.64 Mn |
Galectin Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=GALT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();